Nakajima, Masao
Hazama, Shoichi
Tamada, Koji
Udaka, Keiko
Kouki, Yasunobu
Uematsu, Toshinari
Arima, Hideki
Saito, Akira
Doi, Shun
Matsui, Hiroto
Shindo, Yoshitaro
Matsukuma, Satoshi
Kanekiyo, Shinsuke
Tokumitsu, Yukio
Tomochika, Shinobu
Iida, Michihisa
Yoshida, Shin
Nakagami, Yuki
Suzuki, Nobuaki
Takeda, Shigeru
Yamamoto, Shigeru
Yoshino, Shigefumi
Ueno, Tomio
Nagano, Hiroaki
Funding for this research was provided by:
NEC Corporation
NEC Corporation (noen)
CYTLIMIC Inc.
Article History
Received: 28 August 2019
Accepted: 12 February 2020
First Online: 26 March 2020
Compliance with ethical standards
:
: Consent for publication was obtained from all patients. In addition, all authors agree with the publication of this manuscript.
: The study protocol was approved by the Institutional Ethics Review Boards of Yamaguchi University (No. H27-108), conducted in accordance with the Helsinki Declaration on experimentation on human subjects, and deposited in the UMIN Clinical Trials Registry as UMIN000020440.
: All patients provided written informed consent prior to undergoing any study-related procedure.